Resources Contact Us Home
Pharmaceutical compositions and preparations for treatment of metabolic bone disease

Image Number 4 for United States Patent #6835722.

The present invention relates to a pharmaceutical composition for the treatment of metabolic bone disease and the method of preparation thereof, and more particularly, to an improved pharmaceutical composition for the therapeutic treatment of metabolic disease and the method of preparation thereof, wherein said composition is prepared as a composite pharmaceutical agent which comprises calcitriol; which reduces the rate of spine fractures and increases bone density; alendronate, a bone resorption inhibitor, as two main active ingredients in an optimal mixing ratio to exert the greatest synergistic therapeutic effect; and adequate amount of other additives such as a resorption fortifier of alendronate. Thereof, the pharmaceutical composition according to the present invention can inhibit hypercalcemia caused when administered by calcitriol alone, compensate the inhibitory activity of bone remodeling caused by alendronate due to the presence of calcitriol, and improve drug compliance associated with the usual difficulty in administration as well as a side effect in esophagus, thus effectively preventing the occurence of osteoporosis.

  Recently Added Patents
Recombinant vectors for use in position-independent transgene expression within chromatin
Biological analysis arrangement and approach therefor
Methods and systems for managing electronic messages
Aluminum oxide coated cutting tool and method of manufacturing thereof
Method of sending CTI messages in a communication system
Separate matching models based on type of phone associated with a caller
Wire guide
  Randomly Featured Patents
System and method of disabling an evacuation location device
Color-stable superabsorbent polymer composition
Adjustable glare shield for brim caps
Acoustic survey technique
Rack-mounted module access
Stabilized electromagnetic resonant armature tactile vibrator
Semiconductor field effect device having channel stop and channel region formed in a well and manufacturing method therefor
Mold material with additives
Encapsulated implantable transponder
Evacuated printing platen